Cited by 276Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsVenous Thromboembolism Diagnosis and Management

The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation

Open access
Themistoclakis, Sakis, Corrado, Andrea, Marchlinski, Francis E., Jais, Pierre, Zado, Erica, Rossillo, Antonio, Di Biase, Luigi, Schweikert, Robert A. +11 more·2010·Journal of the American College of Cardiology

Abstract

Objectives The aim of this multicenter study was to evaluate the safety of discontinuing oral anticoagulation therapy (OAT) after apparently successful pulmonary vein isolation.Background Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events (TE) and often requires OAT. Pulmonary vein isolation is considered an effective treatment for AF.Methods We studied 3,355 patients, of whom 2,692 (79% male, mean age 57 +/- 11 years) discontinued OAT 3 to 6 months after ablation (Off-OAT group) and 663 (70% male, mean age 59 +/- 11 years) remained on OAT after this period (On-OAT group). CHADS(2) (congestive heart failure, hypertension, age [75 years and older], diabetes mellitus, and a history of stroke or transient ischemic attack) risk scores of 1 and > or =2 were recorded in 723 (27%) and 347 (13%) Off-OAT group patients and in 261 (39%) and 247 (37%) On-OAT group patients, respectively.Results During follow-up (mean 28 +/- 13 months vs. 24 +/- 15 months), 2 (0.07%) Off-OAT group patients and 3 (0.45%) On-OAT group patients had an ischemic stroke (p = 0.06). No other thromboembolic events occurred. No Off-OAT group patient with a CHADS(2) risk score of > or =2 had an ischemic stroke. A major hemorrhage was observed in 1 (0.04%) Off-OAT group patient and 13 (2%) On-OAT group patients (p < 0.0001).Conclusions In this nonrandomized study, the risk-benefit ratio favored the suspension of OAT after successful AF ablation even in patients at moderate-high risk of TE. This conclusion needs to be confirmed by future large randomized trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2009.11.039

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibril- lation. Heart Rhythm 2007;4:816 -61.

Cited by

Sorted by citations

Authors
Themistoclakis, S., Corrado, A., Marchlinski, F. E., Jais, P., Zado, E., Rossillo, A., Di Biase, L., Schweikert, R. A., Saliba, W. I., Horton, R., Mohanty, P., Patel, D., Burkhardt, D. J., Wazni, O. M., Bonso, A., Callans, D. J., Haissaguerre, M., Raviele, A., & Natale, A.
Affiliations
  • Ospedale dell' Angelo (IT)
  • University of Pennsylvania (US)
  • Cleveland Clinic Akron General (US)
  • Cleveland Clinic (US)
  • St David's Medical Center (US)
Corresponding author
Raviele, Antonio
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2010-02
Volume
55
Issue
8
Pages
735-743
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2014353486
Cited by
276
References
31
Citations by year
2026: 7 · 2025: 2 · 2024: 9 · 2023: 5 · 2022: 9 · 2021: 10 · 2020: 21 · 2019: 13 · 2018: 16 · 2017: 22 · 2016: 19 · 2015: 21 · 2014: 26 · 2013: 25 · 2012: 34
FWCI
19.97
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Biosense Webster
  • Medtronic
  • St. Jude Medical
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords
atrial fibrillation, oral anticoagulation, anticoagulation discontinuation, pulmonary vein isolation, catheter ablation, thromboembolism, ischemic stroke, major bleeding, CHADS2 score, risk-benefit assessment
MeSH terms
Administration, Oral, Aged, Anticoagulants, Atrial Fibrillation, Female, Humans, Male, Middle Aged, Pulmonary Veins, Risk Factors, Thromboembolism, Time Factors, Treatment Outcome, Catheter Ablation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review